Medicare step therapy is a cost-control rule that decides which drug your plan pays for first. Under this policy, your Part D or Medicare Advantage plan asks you to try a preferred medication before it will cover a more expensive alternative. Insurers sometimes call it “fail first.” The name is blunt but accurate.
You must show the cheaper drug did not work, or that it caused problems, before the plan approves the drug your doctor originally wrote. Millions of beneficiaries hit this rule every year without warning. It often surfaces at the pharmacy counter, when a prescription that was covered in December suddenly rejects in January. Understanding medicare step therapy before that moment can save you weeks of delay and hundreds of dollars in out-of-pocket costs.
How Part D Plans Decide Which Drugs Come First
Every Part D plan builds a formulary, which is its list of covered drugs. CMS reviews that formulary each year. Plans then layer on utilization management tools. There are three main tools: prior authorization, quantity limits, and step therapy. According to KFF analysis of 2024 formulary data, roughly 50% of Part D drugs carried some form of utilization management. About 54% of stand-alone drug plan enrollees were affected. Quantity limits touched 42% of enrollees. Prior authorization touched roughly 32%.
Step therapy usually targets expensive drug classes. Think biologics for rheumatoid arthritis, specialty oncology drugs, newer diabetes medications, and brand-name drugs with generic competition. For example, a plan may require metformin before covering a newer GLP-1 agent. Research on specialty drug policies found step therapy applied in roughly 39% of coverage policies at large plans. That same research found more than half of those protocols were stricter than published clinical guidelines.
Plans are not identical. UnitedHealthcare, Humana, Aetna, Cigna, Blue Cross plans, and Mutual of Omaha each publish their own criteria. One plan may require a single trial drug. Another may require two. As a result, the exact same prescription can sail through at one insurer and stall at another. That variation is why the formulary matters more than the premium for people on maintenance drugs.
Medicare Step Therapy Rules for Part B and Part D Drugs
The rules split by benefit. Part D covers drugs you pick up at a pharmacy. Part B covers drugs a clinician administers, such as infusions given in an office or hospital outpatient setting. Since 2019, CMS has allowed Medicare Advantage plans to apply medicare step therapy to Part B drugs as well. The governing regulation is 42 CFR 422.136. Original Medicare, by contrast, does not apply step therapy to Part B drugs. That difference is one of the real trade-offs when choosing between Original Medicare and a Medicare Advantage plan.
CMS built guardrails into the Part B rule. A Medicare Advantage plan may only require an enrollee to try one alternative drug before covering the requested one. Commercial plans face no such federal cap. Plans must review and approve every step therapy criterion they apply. They must also evaluate their protocols at least annually and document those decisions. Off-label indications may be used in a protocol only when supported by widely accepted treatment guidelines or clinical literature.
Timelines are set in federal regulation too. The table below shows the deadlines your plan must meet.
| Request type | Deadline for plan decision | Clock starts when |
|---|---|---|
| Standard Part D coverage determination | 72 hours | Plan receives the request |
| Expedited Part D coverage determination | 24 hours | Plan receives the request |
| Standard exception request | 72 hours | Plan receives prescriber’s supporting statement |
| Expedited exception request | 24 hours | Plan receives prescriber’s supporting statement |
| Part B drug request (Medicare Advantage) | 72 hours standard, 24 hours expedited | Plan receives the request |
Missing the deadline is not a small thing. If a plan blows the clock, federal rules treat that failure as a denial. The plan must then forward your case to the Independent Review Entity within 24 hours.
How to Request an Exception and Win It
You do not have to accept a step therapy requirement. CMS treats a request to waive it as a formulary exception. The process has a specific shape, and following it closely improves your odds. Start by asking your plan for a coverage determination. You can call the number on your member card or file online. Your prescriber can file on your behalf, and in practice that is faster.
The prescriber’s supporting statement is the deciding document. It must say that the required alternative drug has been tried and was less effective, or that it is expected to be less effective, or that it would likely cause an adverse reaction. Vague statements get denied. Specific ones get approved. A strong statement names the alternative drug, the dates tried, the clinical result, and the guideline supporting the requested drug. Attach chart notes and lab values when you have them.
Ask for an expedited decision when waiting could seriously harm your health. That cuts the deadline from 72 hours to 24. If the plan says no, you have five levels of appeal available: plan redetermination, review by the Independent Review Entity, an Administrative Law Judge hearing, the Medicare Appeals Council, and finally federal district court. Many denials are reversed at the first or second level, so do not stop after one no.
Three practical moves protect you. First, check next year’s formulary during Open Enrollment, which runs October 15 through December 7. Plans change utilization rules every January. Second, ask your pharmacist to run a test claim in December on your current medications. Third, request a transition fill. Part D plans must generally provide at least a 30-day temporary supply during the first 90 days of the plan year for drugs you were already taking. That fill buys time to file paperwork.
❤️ Get Free Medicare Guides
Free · No spam · Unsubscribe anytime
Free help exists. Every state runs a State Health Insurance Assistance Program, known as SHIP, staffed by trained counselors who charge nothing. AARP publishes plain-language explainers. Medicare.gov’s Plan Finder tool flags which drugs on a plan’s formulary carry step therapy, prior authorization, or quantity limits before you enroll. Use that flag column. It is the single fastest way to compare plans on the rules that will actually affect your prescriptions.
Frequently Asked Questions
Can my plan add medicare step therapy to a drug in the middle of the year?
Generally no, not for someone already stabilized on the drug. CMS limits mid-year negative formulary changes for current users. However, plans can add restrictions for new starts, and rules can change fully at the January plan year reset.
Does Original Medicare use step therapy?
Original Medicare does not apply step therapy to Part B drugs. Your stand-alone Part D drug plan still can, since every Part D plan is run by a private insurer. Medicare Advantage plans may apply it to both Part B and Part D drugs.
What happens if I already tried the required drug at a former plan?
Prior trials usually count, but the new plan needs proof. Ask your prescriber to document the earlier medication, the dates, and the outcome in the supporting statement. In most cases that history satisfies the requirement without repeating the trial.
How long does a medicare step therapy exception last once approved?
Approvals are typically granted for the remainder of the plan year. Some plans approve a set period, such as 12 months. Mark the expiration date and start renewal paperwork about 30 days early to avoid a gap at the pharmacy.
Compare Medicare Options
Ready to explore your Medicare coverage choices? Comparing plans from multiple carriers is the most effective way to find the right coverage at the best rate for your situation.
(paid link)
Official Sources & Resources
For verified information on Medicare regulations and consumer protection:
- Medicare.gov (Official Site): medicare.gov
- CMS (Centers for Medicare & Medicaid Services): cms.gov
- NAIC (National Association of Insurance Commissioners): naic.org
- KFF Medicare Research: kff.org/medicare
- Social Security Administration: ssa.gov
Content last reviewed July 2026. If you notice any outdated information, please contact us.